Integer Holdings (ITGR) Liabilities and Shareholders Equity (2010 - 2026)
Integer Holdings (ITGR) posted Liabilities and Shareholders Equity of $3.4 billion for Q2 2026, little changed sequentially from $3.4 billion in Q4 2025, and up 3.46% YoY from $3.3 billion in Q2 2025.
Integer Holdings (ITGR) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends
Integer Holdings has reported Liabilities and Shareholders Equity for 17 years, with the latest figure at $3.4 billion in Q2 2026.
- Quarterly Liabilities and Shareholders Equity rose 3.46% year-over-year to $3.4 billion in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $13.6 billion (up 7.27% YoY) and the FY2025 annual result came in at $3.4 billion, up 10.81% from the prior year.
- Liabilities and Shareholders Equity was little changed at $3.4 billion in Q2 2026 per ITGR's latest filing, from $3.4 billion in the prior quarter.
- Over five years, Liabilities and Shareholders Equity peaked at $3.4 billion in Q2 2026 and troughed at $2.6 billion in Q2 2022.
- A 5-year average of $3.0 billion and a median of $3.1 billion in 2024 frame the typical range for Liabilities and Shareholders Equity.
- The sharpest annual moves came in 2022 and 2026: Liabilities and Shareholders Equity climbed 16.91% in 2022, then grew 3.46% in 2026.
- Over 5 years, Liabilities and Shareholders Equity stood at $2.8 billion in 2022, then grew by 5.31% to $2.9 billion in 2023, then gained by 4.6% to $3.1 billion in 2024, then increased by 10.81% to $3.4 billion in 2025, then grew by 0.03% to $3.4 billion in 2026.
- According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $3.4 billion, $3.4 billion, and $3.4 billion for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 109.22 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 47.93 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 93.03 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 13.87 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 6.46 Bn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 37.25 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 31.04 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 10.74 Bn |
| 10 | Integer Holdings | 4.26 Bn | 4.24 Bn | 112.94 Mn | 3.42 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 3, 2026 | 3.42 Bn |
| Apr 3, 2026 | 3.41 Bn |
| Dec 31, 2025 | 3.41 Bn |
| Sep 26, 2025 | 3.40 Bn |
| Jun 27, 2025 | 3.37 Bn |
| Mar 28, 2025 | 3.30 Bn |
| Dec 31, 2024 | 3.08 Bn |
| Sep 27, 2024 | 3.17 Bn |
| Jun 28, 2024 | 3.13 Bn |
| Mar 29, 2024 | 3.12 Bn |
| Dec 31, 2023 | 2.94 Bn |
| Sep 29, 2023 | 2.84 Bn |
| Jun 30, 2023 | 2.86 Bn |
| Mar 31, 2023 | 2.87 Bn |
| Dec 31, 2022 | 2.79 Bn |
| Sep 30, 2022 | 2.74 Bn |
| Jul 1, 2022 | 2.76 Bn |
| Apr 1, 2022 | 2.61 Bn |
| Dec 31, 2021 | 2.58 Bn |
| Oct 1, 2021 | 2.35 Bn |